Bolt Biotherapeutics (BOLT) Other financing activities (2021)

Bolt Biotherapeutics (BOLT) posted Other financing activities of -$672000.0 for Q2 2021, down 100.27% sequentially from $245.0 million in Q1 2021.

Bolt Biotherapeutics (BOLT) Other financing activities (2021) Analysis & Trends

Bolt Biotherapeutics has reported Other financing activities for 1 years, with the latest figure at -$672000.0 in Q2 2021.

Quarterly Other financing activities changed N/A year-over-year to -$672000.0 in Q2 2021, while the trailing twelve-month figure through Dec 2021 was $244.3 million (changed N/A YoY) and the FY2021 annual result came in at $244.3 million, changed N/A from the prior year.
Other financing activities retreated to -$672000.0 in Q2 2021 per BOLT's latest filing, from $245.0 million in the prior quarter.
Over five years, Other financing activities peaked at $245.0 million in Q1 2021 and troughed at -$672000.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Bolt Biotherapeutics	6.10 Mn	6.10 Mn	-

Download Data